Novel sphingosine kinases
    1.
    发明申请
    Novel sphingosine kinases 审中-公开
    新型鞘氨醇激酶

    公开(公告)号:US20050123942A1

    公开(公告)日:2005-06-09

    申请号:US10876281

    申请日:2004-06-24

    摘要: Disclosed herein are novel human nucleic acid sequences that encode polypeptides. Also disclosed are polypeptides encoded by these nucleic acid sequences, and antibodies that immunospecifically-bind to the polypeptide, as well as derivatives, variants, mutants, or fragments of the aforementioned polypeptide, polynucleotide, or antibody. The invention further discloses therapeutic, diagnostic and research methods for diagnosis, treatment, and prevention of disorders involving any one of these novel human nucleic acids and proteins.

    摘要翻译: 本文公开了编码多肽的新型人核酸序列。 还公开了由这些核酸序列编码的多肽,以及免疫特异性结合多肽的抗体,以及上述多肽,多核苷酸或抗体的衍生物,变体,突变体或片段。 本发明还公开了用于诊断,治疗和预防与这些新型人核酸和蛋白质中的任一种相关的病症的治疗,诊断和研究方法。

    ErbB4 antagonists
    4.
    发明申请
    ErbB4 antagonists 审中-公开
    ErbB4拮抗剂

    公开(公告)号:US20070092513A1

    公开(公告)日:2007-04-26

    申请号:US11581221

    申请日:2006-10-13

    IPC分类号: A61K39/395

    摘要: The present invention concerns methods and means for controlling excessive proliferation and/or migration of smooth muscle cells, and in particular for treating stenosis, by using antagonists of a native ErbB4 receptor. The invention further concerns a method for the identification of ErbB4 agonists and antagonists capable of inhibiting or enhancing the proliferation or migration of smooth muscle cells.

    摘要翻译: 本发明涉及通过使用天然ErbB4受体的拮抗剂来控制平滑肌细胞的过度增殖和/或迁移,特别是用于治疗狭窄的方法和手段。 本发明还涉及鉴定能够抑制或增强平滑肌细胞增殖或迁移的ErbB4激动剂和拮抗剂的方法。